FROVOCIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

FROVOCIMAB

Official Name

English

LY3015014

Code

English

IMMUNOGLOBULIN G4, ANTI-(PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9(PCSK9))(HUMAN MONOCLONAL LY3015014 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3015014 LIGHT-CHAIN, DIMER

Systematic Name

English

FROVOCIMAB [USAN]

Common Name

English

Frovocimab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (NEURAL APOPTOSIS-REGULATED CONVERTASE 1, PROPROTEIN CONVERTASE 9, SUBTILISIN/KEXIN-LIKE PROTEASE PC9, EC=3.4.21.-))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-45

Systematic Name

English

LY-3015014

Code

English

frovocimab [INN]

Common Name

English

Code System Code Type Description

CAS

1643672-70-1

Created by admin on Sat Dec 16 08:00:58 GMT 2023 , Edited by admin on Sat Dec 16 08:00:58 GMT 2023

PRIMARY

FDA UNII

87PZ955YRB

Created by admin on Sat Dec 16 08:00:58 GMT 2023 , Edited by admin on Sat Dec 16 08:00:58 GMT 2023

PRIMARY

USAN

EF-59

Created by admin on Sat Dec 16 08:00:58 GMT 2023 , Edited by admin on Sat Dec 16 08:00:58 GMT 2023

PRIMARY

INN

10859

Created by admin on Sat Dec 16 08:00:58 GMT 2023 , Edited by admin on Sat Dec 16 08:00:58 GMT 2023

PRIMARY

NCI_THESAURUS

C175068

Created by admin on Sat Dec 16 08:00:58 GMT 2023 , Edited by admin on Sat Dec 16 08:00:58 GMT 2023

PRIMARY

DRUG BANK

DB15089

Created by admin on Sat Dec 16 08:00:58 GMT 2023 , Edited by admin on Sat Dec 16 08:00:58 GMT 2023

PRIMARY

ACTIVE MOIETY


					87PZ955YRB